Salem Investment Counselors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79K | Hold |
200
| – | – | ﹤0.01% | 1044 |
|
|
2025
Q1 | $1.5K | Hold |
200
| – | – | ﹤0.01% | 1075 |
|
|
2024
Q4 | $1.5K | Hold |
200
| – | – | ﹤0.01% | 1053 |
|
|
2024
Q3 | $1.52K | Hold |
200
| – | – | ﹤0.01% | 1055 |
|
|
2024
Q2 | $1.24K | Hold |
200
| – | – | ﹤0.01% | 1060 |
|
|
2024
Q1 | $1.02K | Hold |
200
| – | – | ﹤0.01% | 1091 |
|
|
2023
Q4 | $1.2K | Hold |
200
| – | – | ﹤0.01% | 1019 |
|
|
2023
Q3 | $1.42K | Hold |
200
| – | – | ﹤0.01% | 1003 |
|
|
2023
Q2 | $1.41K | Hold |
200
| – | – | ﹤0.01% | 1038 |
|
|
2023
Q1 | $1.67K | Buy |
+200
| New | +$1.67K | ﹤0.01% | 995 |
|